Steroid Administration for Post‐COVID ‐19 Parkinsonism: A Case Report

Witoon Mitarnun,Metha Apiwattanakul,Thanatchanan Thodthasri,Praewa Tantisungvarakoon,Wilasinee Pangwong

Neurology and Clinical Neuroscience（2022）

引用 1|浏览2

暂无评分

摘要

A 45-year-old man developed parkinsonism 3 weeks after being diagnosed with mild COVID-19. Levodopa and benserazide failed to improve his symptoms, necessitating ropinirole, and steroid treatment, which included a 5-day course of methylprednisolone followed by a 3-month oral prednisolone taper. One month after initiating steroid treatment, his symptoms improved significantly.

查看译文

关键词

antiparkinsonian medication, COVID-19, Parkinsonism, severe acute respiratory syndrome coronavirus 2, steroids

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要